Harbor Capital Advisors Inc. Has $8.16 Million Stock Holdings in Addus HomeCare Co. (NASDAQ:ADUS)

Harbor Capital Advisors Inc. grew its position in Addus HomeCare Co. (NASDAQ:ADUS) by 1.2% in the 4th quarter, Holdings Channel reports. The institutional investor owned 65,113 shares of the company’s stock after purchasing an additional 802 shares during the period. Harbor Capital Advisors Inc.’s holdings in Addus HomeCare were worth $8,162,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the company. Point72 Asset Management L.P. boosted its stake in Addus HomeCare by 73.4% in the second quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock valued at $86,598,000 after acquiring an additional 315,602 shares during the last quarter. Millennium Management LLC boosted its position in shares of Addus HomeCare by 412.7% in the 2nd quarter. Millennium Management LLC now owns 316,418 shares of the company’s stock worth $36,739,000 after purchasing an additional 254,705 shares during the last quarter. Wasatch Advisors LP grew its stake in shares of Addus HomeCare by 11.8% during the third quarter. Wasatch Advisors LP now owns 1,043,240 shares of the company’s stock worth $138,782,000 after purchasing an additional 110,010 shares during the period. Ghisallo Capital Management LLC acquired a new position in Addus HomeCare in the second quarter valued at about $11,611,000. Finally, Principal Financial Group Inc. boosted its holdings in Addus HomeCare by 17.5% during the third quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock worth $67,293,000 after buying an additional 75,409 shares during the last quarter. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Trading Down 1.2 %

Shares of Addus HomeCare stock traded down $1.58 during trading hours on Friday, reaching $124.84. 43,458 shares of the company’s stock were exchanged, compared to its average volume of 121,477. The company has a 50 day moving average of $125.04 and a two-hundred day moving average of $125.95. The stock has a market cap of $2.26 billion, a P/E ratio of 28.57, a P/E/G ratio of 2.11 and a beta of 1.00. Addus HomeCare Co. has a fifty-two week low of $85.94 and a fifty-two week high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm had revenue of $289.80 million during the quarter, compared to the consensus estimate of $289.42 million. During the same period last year, the company earned $1.03 earnings per share. The business’s revenue was up 7.1% compared to the same quarter last year. As a group, analysts expect that Addus HomeCare Co. will post 4.59 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of analysts recently weighed in on ADUS shares. JMP Securities assumed coverage on shares of Addus HomeCare in a research report on Monday, December 16th. They issued an “outperform” rating and a $150.00 price target on the stock. Oppenheimer lifted their price target on shares of Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research report on Monday, September 23rd. KeyCorp assumed coverage on shares of Addus HomeCare in a report on Friday, October 11th. They issued an “overweight” rating and a $150.00 price target for the company. Royal Bank of Canada reissued an “outperform” rating and issued a $136.00 target price on shares of Addus HomeCare in a research note on Thursday, November 14th. Finally, Citizens Jmp upgraded Addus HomeCare to a “strong-buy” rating in a research report on Monday, December 16th. One investment analyst has rated the stock with a sell rating, nine have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $133.67.

Insider Buying and Selling

In related news, CEO R Dirk Allison sold 25,000 shares of the stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total value of $3,119,000.00. Following the sale, the chief executive officer now owns 79,397 shares in the company, valued at approximately $9,905,569.72. This represents a 23.95 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Roberton James Stevenson sold 2,250 shares of Addus HomeCare stock in a transaction on Monday, December 9th. The stock was sold at an average price of $121.00, for a total transaction of $272,250.00. Following the transaction, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at approximately $1,236,257. This trade represents a 18.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 39,750 shares of company stock worth $4,930,750. Insiders own 4.60% of the company’s stock.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.